Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: Initial experience of a community-based hospital in a developing country

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 1, 2012, Pages 42-46

  Muengtaweepongsa, Sombat ^a   Dharmasaroja, Pornpatr ^a   Kummark, Urai ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

acute stroke treatment; intravenous rt PA; Stroke fast track; thrombolytic rate

Indexed keywords

ALTEPLASE;

ACUTE ISCHEMIC STROKE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT TOOL; COMMUNITY HOSPITAL; DEVELOPING COUNTRY; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED RANKIN SCALE SCORE; MORBIDITY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; COMMUNITY NETWORKS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PROSPECTIVE STUDIES; STROKE; THAILAND; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 84855493118     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.03.017     Document Type: Article

References (19)

1. Lopez AD, Mathers CD, Ezzati M,et al. Global and regional burden of disease andrisk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-1757. (Pubitemid 43767064)
2. Asian Acute Stroke Advisory Panel (AASAP). Stroke epidemiological data of nine Asian countries. J Med Assoc Thai 2000;83:1-7.
3. Poungvarin N. Burden of stroke in Thailand. Int J Stroke 2007;2:127-128. (Pubitemid 46691710)
4. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: Aguideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007;38:1655-1711. (Pubitemid 46691097)
5. Guidelines for management of ischaemic stroke and transient ischemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
6. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
7. Durai Pandian J, Padma V, Vijaya P, et al. Stroke and thrombolysis in developing countries. Int J Stroke 2007;2:17-26. (Pubitemid 46195629)
8. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation. Clin Neurol Neurosurg 2006;108:549-552. (Pubitemid 44189093)
9. Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol 2007;6:553-561. (Pubitemid 46734756)
10. Suwanwela NC, Phanthumchinda K, Suwanwela N, et al. Thrombolytic treatment for acute ischemic stroke: A 2-year experience at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2001;84(Suppl 1):S428-S436. (Pubitemid 33714878)
11. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 2000;283:1151-1158. (Pubitemid 30126603)
12. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischemic stroke: Successful implementation in an Australian tertiary hospital. Intern Med J 2006;36:483-488. (Pubitemid 43990899)
13. Grond M, Stenzel C, Schmulling S, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544-1549. (Pubitemid 28365571)
14. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience, 1996 to 2000. Arch Neurol 2001;58:2009-2013. (Pubitemid 33143979)
15. Szoeke CE, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003;178:324-328. (Pubitemid 36503093)
16. Kobayashi A, Skowronska M, Litwin T, et al. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated. Emerg Med J 2007;24:96-99. (Pubitemid 46210624)
17. Bravata DM, Kim N, Concato J, et al. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002;162:1994-2001.
18. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
19. Thrombolytic therapy for acute ischemic stroke. Can J Emerg Med 2001;3:8-12.